Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) EBIT (2020 - 2026)

Aveanna Healthcare Holdings' EBIT history spans 7 years, with the latest figure at $71.0 million for Q1 2026.

  • For Q1 2026, EBIT rose 55.22% year-over-year to $71.0 million; the TTM value through Jan 2026 reached $256.5 million, up 83.47%, while the annual FY2026 figure was $256.5 million, 83.47% up from the prior year.
  • EBIT reached $71.0 million in Q1 2026 per AVAH's latest filing, up from $53.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $80.0 million in Q2 2025 to a low of -$456.4 million in Q3 2022.
  • Average EBIT over 5 years is -$14.9 million, with a median of $29.3 million recorded in 2023.
  • Peak YoY movement for EBIT: crashed 1694.99% in 2023, then surged 144.56% in 2024.
  • A 5-year view of EBIT shows it stood at -$204.5 million in 2022, then surged by 114.33% to $29.3 million in 2023, then skyrocketed by 56.25% to $45.8 million in 2024, then increased by 17.07% to $53.6 million in 2025, then surged by 32.59% to $71.0 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's EBIT are $71.0 million (Q1 2026), $53.6 million (Q3 2025), and $80.0 million (Q2 2025).